BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22433469)

  • 1. Acute compartment syndrome of the forearm as a rare complication of toxic epidermal necrolysis: a case report.
    Kamal T; Elnikety S; Mashaly H; Casha J
    J Med Case Rep; 2012 Mar; 6():84. PubMed ID: 22433469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug-induced toxic epidermal necrolysis with secondary aspergillus fumigatus infection: a case report].
    Zhang S; Liu XY; Zhang JZ; Cai L; Zhou C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 51(5):977-980. PubMed ID: 31624410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol-Induced Uncommon Dermatological Emergency of Toxic Epidermal Necrolysis (TEN).
    Pabani UK; Khan Z; Ali L; Shah SK; Khan JA
    Cureus; 2023 Sep; 15(9):e44812. PubMed ID: 37809172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal case of cephalexin-induced toxic epidermal necrolysis.
    Hafermann MJ; Barber GR; Dreskin SC; Lindberg GK
    SAGE Open Med Case Rep; 2014; 2():2050313X14532250. PubMed ID: 27489646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic epidermal necrolysis in a female with metastatic breast cancer treated with vinorelbine.
    Bazine A; Fetohi M; Namad T; El Benaye J; Ennouhi MA; Mahfoud T; Ichou M
    Ann Burns Fire Disasters; 2017 Dec; 30(4):261-263. PubMed ID: 29983677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin: a probable cause of toxic epidermal necrolysis.
    Melde SL
    Ann Pharmacother; 2001 Nov; 35(11):1388-90. PubMed ID: 11724089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Toxic Epidermal Necrolysis Caused by the Use of Trimethoprim Alone.
    Sood M; Oyibo SO; Rajkanna J
    Cureus; 2021 Apr; 13(4):e14783. PubMed ID: 33948423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis associated with pembrolizumab.
    Cai ZR; Lecours J; Adam JP; Marcil I; Blais N; Dallaire M; Belisle A; Mathieu A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1259-1265. PubMed ID: 31810421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
    Fallon MJ; Heck JN
    J Oncol Pharm Pract; 2015 Oct; 21(5):388-92. PubMed ID: 25005569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Persistant mucosal ulcerations: a rare complication of toxic epidermal necrolysis].
    Sibaud V; Fricain JC; Léauté-Labrèze C; Campana F; Taieb A
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 1):682-5. PubMed ID: 16230919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre.
    Mahar PD; Wasiak J; Paul E; Watters DA; Kirby J; Gin D; Marsh P; Cleland H
    Burns; 2014 Dec; 40(8):1743-7. PubMed ID: 24814156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report of hydralazine-induced skin reaction: Probable toxic epidermal necrolysis (TEN).
    Mahfouz A; Mahmoud AN; Ashfaq PA; Siyabi KH
    Am J Case Rep; 2014; 15():135-8. PubMed ID: 24719674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis.
    Hanken I; Schimmer M; Sander CA
    J Dtsch Dermatol Ges; 2010 May; 8(5):341-6. PubMed ID: 19845819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with toxic epidermal necrolysis syndrome revisited.
    Ducic I; Shalom A; Rising W; Nagamoto K; Munster AM
    Plast Reconstr Surg; 2002 Sep; 110(3):768-73. PubMed ID: 12172137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin rash in the intensive care unit: Stevens-Johnson syndrome, toxic epidermal necrolysis, or a rare manifestation of a hidden cutaneous malignancy: A case report.
    Al-Saffar F; Ibrahim S; Patel P; Jacob R; Palacio C; Cury J
    Mol Clin Oncol; 2016 Mar; 4(3):413-415. PubMed ID: 26998294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis after acute burn injury.
    Concannon E; Kennedy S; Shelley O
    Ann Burns Fire Disasters; 2018 Dec; 31(4):266-270. PubMed ID: 30983926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin-induced toxic epidermal necrolysis.
    Sahin MT; Ozturkcan S; Inanir I; Filiz EE
    Ann Pharmacother; 2005 Apr; 39(4):768-70. PubMed ID: 15713789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.